Join        Login             Stock Quote

Maven Semantic: Bioavailability Research Database

Thursday, March 24, 2011 6:55 AM

Search Over 30,000 People and Over 2,000 Research Organisations

Mar. 24, 2011 (Business Wire) -- Maven Semantic (http://www.mavensemantic.com) announces updates to their Bioavailability research database.

The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

The database currently tags 30,000 individuals working in Bioavailability. http://bit.ly/fhRiwB.

Top 10 Countries for Bioavailability Research (ranked by number of senior researchers)

  • United States Of America (11,842)
  • United Kingdom (1,731)
  • Germany (1,447)
  • Japan (1,174)
  • France (1,150)
  • China (1,125)
  • Italy (961)
  • Canada (879)
  • India (699)
  • Spain (692)

Leading organisations in Bioavailability research include:

  • Baylor College of Medicine
  • Boston University School of Medicine
  • Brigham and Women's Hospital
  • Bristol-Myers Squibb Pharmaceutical Research Institute
  • China Pharmaceutical University
  • Cornell University
  • Duke University Medical Center
  • Emory University School of Medicine
  • Ghent University
  • Harvard Medical School
  • Institute of Food Research
  • King's College London
  • Massachusetts General Hospital
  • Medical University of South Carolina
  • National Cancer Institute
  • National Institutes of Health
  • National University of Singapore
  • Northwestern University
  • Pharmaceutical Research Institute
  • Research Center for Eco-Environmental Sciences
  • Swedish University of Agricultural Sciences
  • The Hebrew University of Jerusalem
  • University of British Columbia
  • University of California
  • University of Georgia
  • University of Glasgow
  • University of Helsinki
  • University of Illinois
  • University of Iowa
  • University of Kentucky
  • University of London
  • University of Manchester
  • University of Manitoba
  • University of Maryland
  • University of Toronto
  • Uppsala University
  • Yale University School of Medicine
  • Zhejiang University

The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Bioavailability research field.

Sample companies in database include:

  • Actelion Pharmaceuticals Ltd
  • Agouron Pharmaceuticals, Inc
  • ALZA Corporation
  • Amgen Inc
  • Astellas Pharma Inc
  • Astra Hässle AB
  • Banyu Pharmaceutical Co., Ltd
  • Basilea Pharmaceutica, Ltd
  • Bayer HealthCare AG
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Boehringer Mannheim GmbH
  • Bristol-Myers Squibb Company
  • Cephalon, Inc
  • Chroma Therapeutics Ltd
  • Chugai Pharmaceutical Co., Ltd
  • Ciba-Geigy Corporation
  • CoCensys, Inc
  • Desitin Arzneimittel GmbH
  • Eisai Co., Ltd
  • Eli Lilly and Company
  • F. Hoffmann-La Roche & Co. Ltd
  • Fujisawa Pharmaceutical Co., Ltd
  • Genentech, Inc
  • Genetic Therapy, Inc
  • Gilead Sciences, Inc
  • GlaxoSmithKline, Inc
  • GlycoMimetics Inc
  • Gradient Corporation
  • Medivir AB
  • Merck & Co., Inc
  • Metabasis Therapeutics, Inc
  • Mitsubishi Pharma Corporation
  • Neurocrine Biosciences, Inc
  • Nippon Shinyaku Co. Ltd
  • Novartis Pharmaceuticals Corporation
  • Roche Products Ltd
  • Shionogi & Co., Ltd
  • Taisho Pharmaceutical Co., Ltd
  • Yamanouchi Pharmaceutical Ltd

What is Maven:

- Largest database of international medical professionals, with over 6,000,000 people and over 500,000 medical organisations;

- All records are downloadable to excel or in-house database, with email, postal address and phone contacts;

- Profile and segment the entire database using over 47,000 diseases and therapeutic areas

For more information visit http://www.mavensemantic.com/

Maven Semantic
Bryan McManmon
Ph: +353 1 4100699

(Source: Business Wire )
(Source: Quotemedia)


Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.